Lilly Centre for Clinical Pharmacology
Singapore, Singapore
4 recruiting
Showing 1–11 of 11 trials
Recruiting
Phase 1
A Study of LY3439539 in Participants With Alzheimer's Disease
Alzheimer Disease
Eli Lilly and Company30 enrolled9 locationsNCT07598370
Recruiting
Phase 1
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
ObesityOverweight
Eli Lilly and Company108 enrolled3 locationsNCT07654972
Recruiting
Phase 1
A Study of LY4088044 in Healthy Participants
Healthy
Eli Lilly and Company104 enrolled6 locationsNCT07090785
Recruiting
Phase 1
A Study of Eltrekibart (LY3041658) in Healthy Participants
Healthy
Eli Lilly and Company60 enrolled1 locationNCT07545590
Recruiting
Phase 1
A Study of LY4302814 in Healthy Participants
Healthy
Eli Lilly and Company150 enrolled2 locationsNCT07566338
Recruiting
Phase 1
A Study of LY3971297 in Healthy Participants
ObesityHypertensionHealthy
Eli Lilly and Company225 enrolled7 locationsNCT06148272
Recruiting
Phase 1
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
ObesityHealthyOverweight+1 more
Eli Lilly and Company216 enrolled5 locationsNCT06945419
Recruiting
Phase 1
A Study of LY4064912 in Healthy Participants and With Overweight or Obesity
HealthyOverweight or Obesity
Eli Lilly and Company144 enrolled3 locationsNCT07152002
Recruiting
Phase 1
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company40 enrolled1 locationNCT07299084
Recruiting
Phase 1
A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy
ObesityOverweight
Eli Lilly and Company84 enrolled2 locationsNCT07225556
Recruiting
Phase 1
A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company20 enrolled1 locationNCT07313813